首页> 美国卫生研究院文献>other >Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration
【2h】

Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration

机译:牛磺去氧胆酸对N-甲基-D-天冬氨酸诱导的视网膜神经节细胞变性的神经保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Retinal ganglion cell degeneration underlies the pathophysiology of diseases affecting the retina and optic nerve. Several studies have previously evidenced the anti-apoptotic properties of the bile constituent, tauroursodeoxycholic acid, in diverse models of photoreceptor degeneration. The aim of this study was to investigate the effects of systemic administration of tauroursodeoxycholic acid on N-methyl-D-aspartate (NMDA)-induced damage in the rat retina using a functional and morphological approach. Tauroursodeoxycholic acid was administered intraperitoneally before and after intravitreal injection of NMDA. Three days after insult, full-field electroretinograms showed reductions in the amplitudes of the positive and negative-scotopic threshold responses, scotopic a- and b-waves and oscillatory potentials. Quantitative morphological evaluation of whole-mount retinas demonstrated a reduction in the density of retinal ganglion cells. Systemic administration of tauroursodeoxycholic acid attenuated the functional impairment induced by NMDA, which correlated with a higher retinal ganglion cell density. Our findings sustain the efficacy of tauroursodeoxycholic acid administration in vivo, suggesting it would be a good candidate for the pharmacological treatment of degenerative diseases coursing with retinal ganglion cell loss.
机译:视网膜神经节细胞变性是影响视网膜和视神经的疾病的病理生理基础。先前的几项研究已证明,在多种光感受器变性模型中,胆汁成分牛磺去氧胆酸的抗凋亡特性。这项研究的目的是使用功能和形态学方法研究牛磺去氧胆酸全身给药对N-甲基-D-天冬氨酸(NMDA)诱导的大鼠视网膜损伤的影响。玻璃体内注射NMDA之前和之后,腹膜内给予牛磺去氧胆酸。侮辱三天后,全场视网膜电图显示正,负暗视阈值响应,暗视a波和b波以及振荡电位的幅度降低。整个视网膜的定量形态学评估显示视网膜神经节细胞密度降低。牛磺去氧胆酸的全身给药减弱了NMDA引起的功能损害,这与较高的视网膜神经节细胞密度有关。我们的发现维持了牛磺去氧胆酸在体内给药的功效,这表明它可作为治疗与视网膜神经节细胞丢失有关的退行性疾病的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号